SAB Biotherapeutics(SABS)
$2.81-0.10 (-3.44%)
SABS
SAB Biotherapeutics similar stocks
$2.81
At close:-0.10 (-3.44%)
Want to see SABS full AI Analyst Report?
Compare SAB Biotherapeutics (SABS) vs. Competitors
331 Followers
Comparison Results
| Name | Price | Market Cap | P/E Ratio | Yearly Gain | Analyst Consensus | Analyst Price Target | Compare | Top Analysts' Price Target | Smart Score | Follow |
|---|---|---|---|---|---|---|---|---|---|---|
| SABSSAB Biotherapeutics | $2.81 | $262.16M | -3.02 | -26.05% | Strong Buy | Unlock the SABS analyst price target with TipRanks Premium | SABS | Unlock the SABS top-analyst price target with TipRanks Premium | ||
| LSTALisata Therapeutics | $0.90 | $9.83M | -0.48 | -54.87% | ― | Unlock the LSTA analyst price target with TipRanks Premium | SABS vs LSTA | Unlock the LSTA top-analyst price target with TipRanks Premium | ||
| NXTCNextCure | $6.45 | $31.05M | -0.74 | -29.97% | ― | Unlock the NXTC analyst price target with TipRanks Premium | SABS vs NXTC | Unlock the NXTC top-analyst price target with TipRanks Premium | ||
| RLYBRallybio | $15.47 | $83.56M | 3.35 | 217.01% | ― | Unlock the RLYB analyst price target with TipRanks Premium | SABS vs RLYB | Unlock the RLYB top-analyst price target with TipRanks Premium |
Performance Comparison
| Ticker | Company Name | Price | Change | % Change | |
|---|---|---|---|---|---|
| SABS | SAB Biotherapeutics | 2.81 | -1.14 | -28.86% | |
| LSTA | Lisata Therapeutics | 0.90 | -1.06 | -54.18% | |
| NXTC | NextCure | 6.45 | -4.06 | -38.63% | |
| RLYB | Rallybio | 15.47 | 10.45 | 208.35% |
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts

